Aram Francis Hezel, M.D.

Aram Francis Hezel, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Administrative: (585) 275-9484
Fax: (585) 273-1042
Office: (585) 275-5823

Bio

The biographical information for Aram Francis Hezel, M.D. is not currently available.

Awards & Honors (Local)

Patient & Family Centered Care Top Performer Award | University of Rochester, American Cancer Society 2013
American Cancer Society Career Development Award 2013
Teacher of the Year Award | University of Rochester, Division of Hematology & Oncology 2012
Teacher of the Year Award | University of Rochester, Division of Hematology & Oncology 2011
Edelman Gardner Research Award | University of Rochester, Wilmot Cancer Center 2010
Howard Hughes Medical Institute Physician-Scientist Early Career Award 2007
NCI Career Development Award: K08 CA122835-03 2006
PanCAN/ASCO Young Investigator Award 2005
Loretta A. Jordan Award for Research of Neoplastic Disease 2000
Robin Bannerman Memorial Research Award 2000
Howard Hughes Medical Institute Research Training Fellowship for Medical Students 1999
Howard Hughes Medical Institute Research Training Fellowship 1998
John Harford/American Federation for Aging Research | Medical School Researc Fellowship 1997
Dean's List for Academic Excellence | SUNY Buffalo School of Medicine 1996 - 1997

Recent Journal Articles

Showing the 5 most recent journal articles. 38 available »

2014
Saha SK, Parachoniak CA, Ghanta KS, Fitamant J, Ross KN, Najem MS, Gurumurthy S, Akbay EA, Sia D, Cornella H, Miltiadous O, Walesky C, Deshpande V, Zhu AX, Hezel AF, Yen KE, Straley KS, Travins J, Popovici-Muller J, Gliser C, Ferrone CR, Apte U, Llovet JM, Wong KK, Ramaswamy S, Bardeesy N. "Mutant IDH inhibits HNF-4? to block hepatocyte differentiation and promote biliary cancer." Nature. 2014; 10.1038/nature13441.
2014
Hezel AF, Noel MS, Allen JN, Abrams TA, Yurgelun M, Faris JE, Goyal L, Clark JW, Blaszkowsky LS, Murphy JE, Zheng H, Khorana AA, Connolly GC, Hyrien O, Baran A, Herr M, Ng K, Sheehan S, Harris DJ, Regan E, Borger DR, Iafrate AJ, Fuchs C, Ryan DP, Zhu AX. "Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer. ." Br J Cancer.;111(3):430-6. doi: 10.1038/bjc.2014.343. Epub 2014 Jun 24. 2014; .
2013
Connolly GC, Safadjou S, Kashyap R, Chen R, Orloff MS, Hezel AF. "Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma." BMC Gastronenterology. 2013; : 139.
2013
McCleary, N.J.; Odejide, O; Szymonifka, J; Ryan, D.P.; Hezel, AF; Meyerhardt, JA. "Safety and Effectiveness of Oxaliplatin-based Chemotherapy Regimens in Adults 75 Years and Older with Colorectal Cancer." Cinical Colorectal Cancer. 2013; 1: 62-9.
2013
Goyal L, Supko JG, Berlin J, Blaszkowsky LS, Carpenter A, Heuman DM, Hilderbrand SL, Stuart KE, Cotler S, Senzer NN, Chan E, Berg CL, Clark JW, Hezel AF, Ryan DP, Zhu AX. "Phase 1 study of N 1,N 11-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma." Phase 1 study of N 1,N 11-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma. 2013; .

Current Appointments

Associate Professor - Department of Medicine, Hematology/Oncology (SMD) - Primary
Associate Professor - Department of Biomedical Genetics (SMD)
Associate Professor - Cancer Center

Specialties

Internal Medicine - American Board of Internal Medicine
Medical Oncology - American Board of Internal Medicine

Education

MD | Medicine | Univ at Buffalo SUNY School of Medicine & Biomedical Sciences2000
BA | Not Specificly Classified | Vassar College1995

Post-Doctoral Training & Residency

Fellowship in Medical Oncology at Dana Farber Cancer Institute/ Partners07/01/2003 - 06/30/2006
Residency in Internal Medicine at Beth Israel Deaconess Medical Center07/01/2001 - 06/30/2003
Internship at Beth Israel Deaconess Medical Center07/01/2000 - 06/30/2001